Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BOLD Boundless Bio, Inc.

已收盘 01-21 16:00:00 EST

1.24

+0.01

+0.81%

盘后1.24

+0.000.00%

19:17 EST

最高1.27	最低1.19	成交量17.06万
今开1.23	昨收1.23	日振幅6.50%
总市值2,776万	流通市值2,041万	总股本2,239万
成交额21.01万	换手率1.04%	流通股本1,646万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BOLD","market":"US","secType":"STK","nameCN":"Boundless Bio, Inc.","latestPrice":1.24,"timestamp":1769029200000,"preClose":1.23,"halted":0,"volume":170556,"hourTrading":{"tag":"盘后","latestPrice":1.24,"preClose":1.24,"latestTime":"19:17 EST","volume":2319,"amount":2875.56,"timestamp":1769041034842,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.008130081300813016,"floatShares":16462050,"shares":22385611,"eps":-2.764393,"marketStatus":"已收盘","change":0.01,"latestTime":"01-21 16:00:00 EST","open":1.23,"high":1.27,"low":1.1901,"amount":210053.22203520001,"amplitude":0.064959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.764393,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1769072400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1711598400000,"exchange":"NASDAQ","adjPreClose":1.23,"preHourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.23,"latestTime":"09:22 EST","volume":1056,"amount":1266.9559584,"timestamp":1769005379372,"change":-0.05,"changeRate":-0.04065,"amplitude":0.04878},"postHourTrading":{"tag":"盘后","latestPrice":1.24,"preClose":1.24,"latestTime":"19:17 EST","volume":2319,"amount":2875.56,"timestamp":1769041034842,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.925833},"requestUrl":"/m/hq/s/BOLD","defaultTab":"news","newsList":[{"id":"1163208228","title":"Boundless Bio Inc：优化产品组合策略，包括终止Potentiate试验，将运营资金延长至2028年下半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1163208228","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163208228?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:09","pubTimestamp":1768910972,"startTime":"0","endTime":"0","summary":"Boundless Bio Inc宣布通过产品组合优先排序计划，显著延长了公司的运营资金期限。这一战略调整包含终止其名为Potentiate的临床试验项目。经过此番优化，公司预计现有资金将足以支持运营至2028年下半年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"1167402543","title":"Boundless Bio公司：BBI-940新药临床试验申请获批，首个人体试验计划于2026年上半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1167402543","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167402543?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:09","pubTimestamp":1768910954,"startTime":"0","endTime":"0","summary":"Boundless Bio公司宣布，其研发的BBI-940新药临床试验申请已正式获得监管机构批准。这一重要进展为公司在2026年上半年启动首个人体临床试验奠定了坚实基础，标志着该创新疗法向临床转化迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2588050287","title":"Boundless Bio, Inc.盘中异动 早盘大幅下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588050287?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:30","pubTimestamp":1764603051,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日23时30分，Boundless Bio, Inc.股票出现异动，股价快速下挫5.13%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。其相关个股中，Q32 Bio Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Q32 Bio Inc.、Kala Bio, Inc.、Aditxt, Inc.较为活跃，换手率分别为1007.10%、828.06%、72.92%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Q32 Bio Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为101.36%、100.45%、64.00%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012330519524eeb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012330519524eeb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2583074775","title":"Boundless Bio, Inc.2025财年第三财季实现净利润-13.88百万美元，同比增加15.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583074775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583074775?lang=zh_cn&edition=full","pubTime":"2025-11-14 00:00","pubTimestamp":1763049659,"startTime":"0","endTime":"0","summary":"11月14日，Boundless Bio, Inc.公布财报，公告显示公司2025财年第三财季净利润为-13.88百万美元，同比增加15.93%；其中营业收入为0.00美元，每股基本收益为-0.62美元。从资产负债表来看，Boundless Bio, Inc.总负债58.55百万美元，其中短期债务3.05百万美元，资产负债比为0.03，流动比率为0.11。机构评级：截至2025年11月14日，当前有2家机构对Boundless Bio, Inc.目标价做出预测，其中目标均价为3.50美元，其中最低目标价为3.00美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000226950290a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000226950290a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD"],"gpt_icon":0},{"id":"2581777251","title":"Boundless Bio, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581777251?lang=zh_cn&edition=full","pubTime":"2025-11-05 03:01","pubTimestamp":1762282910,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日03时01分，Boundless Bio, Inc.股票出现波动，股价急速下挫5.11%。截至发稿，该股报1.30美元/股，成交量4.6255万股，换手率0.21%，振幅4.01%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Terns Pharmaceuticals, Inc.、Metsera, Inc.、Relmada Therapeutics, Inc.涨幅较大，Artelo Biosciences, Inc.、Abpro Holdings, Inc、Biomx Inc.较为活跃，换手率分别为305.04%、117.76%、73.95%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为52.50%、47.93%、40.90%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105030150a6e11cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105030150a6e11cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2558684880","title":"Boundless Bio, Inc.2025财年第二财季实现净利润-15.68百万美元，同比增加7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558684880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558684880?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841669,"startTime":"0","endTime":"0","summary":"8月11日，Boundless Bio, Inc.公布财报，公告显示公司2025财年第二财季净利润为-15.68百万美元，同比增加7.66%；其中营业收入为0.00美元，每股基本收益为-0.70美元。从资产负债表来看，Boundless Bio, Inc.总负债56.76百万美元，其中短期债务1.96百万美元，资产负债比为0.04，流动比率为0.15。机构评级：截至2025年8月11日，当前有2家机构对Boundless Bio, Inc.目标价做出预测，其中目标均价为4.00美元，其中最低目标价为3.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000246a6de0785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000246a6de0785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD"],"gpt_icon":0},{"id":"2558574974","title":"Boundless Bio, Inc.盘中异动 临近收盘大幅下跌5.26%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558574974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558574974?lang=zh_cn&edition=full","pubTime":"2025-08-09 04:00","pubTimestamp":1754683201,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日04时00分，Boundless Bio, Inc.股票出现异动，股价大幅下跌5.26%。截至发稿，该股报1.08美元/股，成交量5.3208万股，换手率0.24%，振幅4.39%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。其相关个股中，Alector, Inc.、Hyperion Defi, Inc.、Jyong Biotech Ltd.涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为705.88%、220.66%、110.05%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Longeveron Inc.，振幅分别为75.81%、73.00%、50.16%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080904000194d86368&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080904000194d86368&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2557596440","title":"Boundless Bio, Inc.盘中异动 急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557596440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557596440?lang=zh_cn&edition=full","pubTime":"2025-08-08 03:51","pubTimestamp":1754596283,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日03时51分，Boundless Bio, Inc.股票出现异动，股价急速跳水5.08%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 、C4 Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1872.45%、234.83%、123.27%，振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ，振幅分别为105.51%、82.50%、59.72%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808035124a47b90a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808035124a47b90a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2555068466","title":"Boundless Bio, Inc.盘中异动 急速下跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555068466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555068466?lang=zh_cn&edition=full","pubTime":"2025-07-30 00:06","pubTimestamp":1753805188,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日00时06分，Boundless Bio, Inc.股票出现波动，股价急速跳水5.65%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Calidi Biotherapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5359.53%、3421.00%、1669.46%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为136.28%、111.54%、75.60%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073000062894c1e289&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073000062894c1e289&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2554708615","title":"Boundless Bio, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554708615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554708615?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:26","pubTimestamp":1753716407,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日23时26分，Boundless Bio, Inc.股票出现异动，股价急速跳水5.14%。截至发稿，该股报1.20美元/股，成交量7.0844万股，换手率0.32%，振幅6.12%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Adial Pharmaceuticals, Inc涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为436.58%、213.50%、123.44%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为125.48%、82.93%、75.48%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段的肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728232647a6c63979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728232647a6c63979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2518077462","title":"Boundless Bio, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518077462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518077462?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:57","pubTimestamp":1741636620,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时57分，Boundless Bio, Inc.股票出现波动，股价大幅下挫5.33%。截至发稿，该股报1.60美元/股，成交量21.9333万股，换手率0.98%，振幅6.51%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6553.54%、3901.81%、1040.86%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035700a26ab9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035700a26ab9cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2517864167","title":"Boundless Bio, Inc.盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517864167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517864167?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:09","pubTimestamp":1741277363,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时09分，Boundless Bio, Inc.股票出现异动，股价大幅拉升5.00%。Boundless Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2901.55%、1902.03%、127.01%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aeon Biopharma, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为68.33%、67.37%、57.40%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000923a262a7fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000923a262a7fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2517926003","title":"Boundless Bio, Inc.盘中异动 下午盘股价大涨5.78%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517926003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517926003?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:27","pubTimestamp":1741206442,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时27分，Boundless Bio, Inc.股票出现波动，股价急速拉升5.78%。截至发稿，该股报1.83美元/股，成交量17.9883万股，换手率0.81%，振幅5.20%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Chimerix, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为974.03%、318.47%、317.09%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为82.59%、54.27%、51.93%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042723abea143b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042723abea143b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2516652889","title":"Boundless Bio, Inc.盘中异动 急速下跌5.18%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652889?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:11","pubTimestamp":1741025496,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时11分，Boundless Bio, Inc.股票出现异动，股价快速下挫5.18%。截至发稿，该股报1.83美元/股，成交量3.1296万股，换手率0.14%，振幅3.24%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4350.56%、185.58%、179.09%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021136989a420f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021136989a420f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2516749573","title":"Boundless Bio, Inc.盘中异动 临近午盘急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516749573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516749573?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:50","pubTimestamp":1740761412,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时50分，Boundless Bio, Inc.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报2.00美元/股，成交量1.5722万股，换手率0.07%，振幅3.16%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3011.58%、494.01%、369.17%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为57.80%、48.19%、46.60%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010050129634399b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010050129634399b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2514852171","title":"Boundless Bio, Inc.盘中异动 早盘股价大涨6.79%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514852171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514852171?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:49","pubTimestamp":1740584943,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时49分，Boundless Bio, Inc.股票出现波动，股价大幅拉升6.79%。截至发稿，该股报1.97美元/股，成交量1.3459万股，换手率0.06%，振幅7.88%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5369.10%、204.11%、188.65%，振幅较大的相关个股有Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为161.02%、43.31%、39.47%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226234903a255092d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226234903a255092d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2513213338","title":"Boundless Bio, Inc.盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513213338?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:13","pubTimestamp":1740158014,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时13分，Boundless Bio, Inc.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报2.10美元/股，成交量11.417万股，换手率0.51%，振幅1.50%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为238.67%、216.50%、128.06%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为72.46%、57.50%、48.35%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222011334988e01cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222011334988e01cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2513929737","title":"Liquity将于3月中旬重新部署V2，建议现有V2用户平仓和关闭贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=2513929737","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513929737?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:25","pubTimestamp":1740155119,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/LiquityProtocol/status/1892943503489179877","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4139","BOLD"],"gpt_icon":0},{"id":"2512199223","title":"Boundless Bio, Inc.盘中异动 下午盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512199223?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:57","pubTimestamp":1739908671,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时57分，Boundless Bio, Inc.股票出现异动，股价大幅下跌5.13%。截至发稿，该股报2.13美元/股，成交量4.8742万股，换手率0.22%，振幅5.36%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为882.07%、212.96%、171.13%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219035752abd3f1eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219035752abd3f1eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2511767691","title":"Boundless Bio, Inc.盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511767691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511767691?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:18","pubTimestamp":1739546294,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时18分，Boundless Bio, Inc.股票出现波动，股价大幅上涨5.36%。截至发稿，该股报2.36美元/股，成交量2765股，换手率0.01%，振幅2.01%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2369.11%、618.37%、471.63%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231814988594d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231814988594d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BOLD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.boundlessbio.com","stockEarnings":[{"period":"1week","weight":-0.0081},{"period":"1month","weight":0.0082},{"period":"3month","weight":-0.1854},{"period":"6month","weight":-0.016},{"period":"1year","weight":-0.5138},{"period":"ytd","weight":0.025}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0044},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.068},{"period":"1year","weight":0.1339},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Boundless Bio, Inc.最初成立于2018年4月10日，原名Pretzel Therapeutics, Inc.，是一家特拉华州公司。2019年7月8日，公司更名为Boundless Bio, Inc.。他们是一家临床阶段的肿瘤学公司，致力于开启癌症治疗的新方式，通过靶向染色体外DNA（ecDNA）来解决癌基因扩增肿瘤患者的显著未满足需求，在超过14%的癌症患者中观察到癌基因扩增的根本原因。他们的使命是成为领先的生物制药公司，利用ecDNA生物学提供变革性的治疗方法，改善和延长患有先前难治性癌基因扩增癌的患者的生命。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.045467},{"month":2,"riseRate":0.25,"avgChangeRate":0.036219},{"month":3,"riseRate":0.666667,"avgChangeRate":0.088311},{"month":4,"riseRate":0.333333,"avgChangeRate":0.028717},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.032827},{"month":6,"riseRate":1,"avgChangeRate":0.142257},{"month":7,"riseRate":0.666667,"avgChangeRate":0.021175},{"month":8,"riseRate":0.5,"avgChangeRate":-0.031707},{"month":9,"riseRate":0.75,"avgChangeRate":0.116011},{"month":10,"riseRate":0,"avgChangeRate":-0.120737},{"month":11,"riseRate":0.75,"avgChangeRate":0.014772},{"month":12,"riseRate":0.75,"avgChangeRate":0.282026}],"exchange":"NASDAQ","name":"Boundless Bio, Inc.","nameEN":"Boundless Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Boundless Bio, Inc.,BOLD,Boundless Bio, Inc.股票,Boundless Bio, Inc.股票老虎,Boundless Bio, Inc.股票老虎国际,Boundless Bio, Inc.行情,Boundless Bio, Inc.股票行情,Boundless Bio, Inc.股价,Boundless Bio, Inc.股市,Boundless Bio, Inc.股票价格,Boundless Bio, Inc.股票交易,Boundless Bio, Inc.股票购买,Boundless Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Boundless Bio, Inc.(BOLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Boundless Bio, Inc.(BOLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}